Skip to content

Syngo Carbon Clinicals (VA41)

by Siemens Healthineers AG

510(k) K251059

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK251059 Date24 Oct 2025ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
QIH
Device Class
Class II
Regulation
21 CFR Part 892.2050
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Syngo Carbon Clinicals (VA41) is a Radiology Information System (RIS) and Picture Archiving and Communication System (PACS) integration platform designed to streamline clinical workflows in radiology departments. It facilitates efficient image interpretation, visualization, reporting, and data management across multiple imaging modalities, enabling standardized access to diagnostic information and supporting AI-driven analytics within a unified workspace.

The device is supplied as a software solution for enterprise imaging environments, intended for use in radiology departments and clinical settings where digital radiology workflows are implemented. It is not classified as a single-use or reusable medical device but rather as a software application requiring installation on compatible IT infrastructure. No sterility or MRI safety classifications are specified, and its regulatory status is confirmed by FDA 510(k) clearance under the Radiology advisory committee, with a decision code of SESE (Substantially Equivalent).

From the manufacturer

Syngo Carbon gives rise to knowledge by providing a highly efficient, high quality and optimized clinical environment, opening up a wide range of possibilities in reading, visualization, reporting, AI implementation, data management, archiving and migration, including unique access to innovation platforms, open source and third party functionality and the most up-to-date software available.

Source: siemens-healthineers.com

Syngo Carbon 2 is a new enterprise imaging and reporting solution from Siemens Healthineers. Designed to improve patient care, Syngo Carbon opens possibilities in image interpretation, reporting, Artificial Intelligence (AI), and Data Management. Syngo Carbon provides extensive tooling and open data models across modalities in one integrated and user-friendly workspace.

Source: siemens-healthineers.com

Other devices from Siemens Healthineers AG

See all devices from Siemens Healthineers AG →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of clinical workflows does Syngo Carbon Clinicals (VA41) help streamline in radiology departments?

    Syngo Carbon Clinicals (VA41) integrates a Radiology Information System (RIS) and Picture Archiving and Communication System (PACS) to optimize workflows for image interpretation, visualization, reporting, and data management. It supports standardized access to diagnostic information across multiple imaging modalities, including AI-driven analytics, all within a unified workspace. This helps radiologists and clinicians efficiently manage digital radiology workflows in enterprise imaging environments.

  • How is Syngo Carbon Clinicals (VA41) supplied and what kind of infrastructure does it require?

    Syngo Carbon Clinicals (VA41) is supplied as a software solution rather than a physical device, meaning it requires installation on compatible IT infrastructure within radiology departments or clinical settings. It is not a single-use or reusable medical device, so it must be integrated into existing systems rather than disposed of or reprocessed after use.

  • Is Syngo Carbon Clinicals (VA41) approved for use in specific regulatory markets, and how was its clearance determined?

    Yes, Syngo Carbon Clinicals (VA41) holds FDA 510(k) clearance under the Radiology advisory committee (decision code: SESE). The clearance was determined through a traditional review process, confirming it is *substantially equivalent* to a legally marketed predicate device. This means the FDA evaluated it based on existing standards for similar radiology software solutions.

  • Does Syngo Carbon Clinicals (VA41) support multiple imaging modalities, and how does it enhance diagnostic workflows?

    While the description does not list specific modalities, Syngo Carbon Clinicals (VA41) is designed to integrate with *multiple imaging modalities* by providing a unified workspace for image interpretation, visualization, and reporting. This consolidation of diagnostic information across modalities—such as X-ray, CT, MRI, or ultrasound—helps reduce fragmentation in workflows, enabling faster, more accurate diagnoses and standardized access to patient data.